Skip to main content
Fig. 1 | Cancer Cell International

Fig. 1

From: Differential expression of VEGFR2 protein in HER2 positive primary human breast cancer: potential relevance to anti-angiogenic therapies

Fig. 1

Scatter dot plot showing individual BRC cases (grey symbols) representing the number of tumor stromal vessels showing unequivocal immunoreactivity for CD34 and VEGFR2 in various BRC subsets. Means and SD are represented by black lines both for CD34 and VEGFR2. Comparisons between VEGFR2 positive vessel counts in HER2+ vs. HR+ BRCs and HER2+ BRCs vs. TNBCs are shown with statistically significant results marked with an asterisk (T test)

Back to article page

Cancer Cell International

ISSN: 1475-2867

Contact us